Canaccord Genuity Maintains Buy on Concentrix, Lowers Price Target to $45
Canaccord Genuity analyst Luke Morison maintains Concentrix (NASDAQ: CNXC ) with a Buy and lowers the price target from $55 to $45.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.